Hybrid Sensor-based Physiological Control of an Implantable Rotary Blood Pump. With over 11 million people needing heart transplants worldwide and only 3000 donor hearts, an effective alternative therapy is needed. The Ventracor Ltd. rotary blood pump is one possible approach whereby a fully implantable mechanical device assists the failing heart. The innovative steps in this research proposal will be a means to robustly and safely control the speed of the pump to meet the metabolic needs of the ....Hybrid Sensor-based Physiological Control of an Implantable Rotary Blood Pump. With over 11 million people needing heart transplants worldwide and only 3000 donor hearts, an effective alternative therapy is needed. The Ventracor Ltd. rotary blood pump is one possible approach whereby a fully implantable mechanical device assists the failing heart. The innovative steps in this research proposal will be a means to robustly and safely control the speed of the pump to meet the metabolic needs of the body. Apart from the obvious health benefits for patients, this will provide the company with a huge market advantage that will also help to bolster the Australian medical device industry.Read moreRead less
New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required ....New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required dimensional stability, impermeability and wear resistance. Following sophisticated experiments of modified materials, the best candidates will be used in prototype devices, for final selection of the optimal materials for the new device.Read moreRead less
Novel computational tools for the analysis of sympathetic nervous system activity. This project will investigate electrical signals from the heart, resulting in novel tools for the assessment of sympathetic nervous system activity. The findings will contribute to advancing Australia's international leading position in health technology and improve community health.
Noval design of a Bi-Ventricular Assist Device (BVAD) Centrifugal Heart Pump as an Implantable Total Artificial Heart. In Australia, 40%(50,797) of all deaths each year are related to heart disease and accounted for 12% (A$4Billion) of total recurrent health expenditure. This innovative research aims at developing a single biventricular assist device (BVAD) driven by a magnetically suspended double-sided centrifugal pump impeller. Current techniques require two implantable devices, thus preventi ....Noval design of a Bi-Ventricular Assist Device (BVAD) Centrifugal Heart Pump as an Implantable Total Artificial Heart. In Australia, 40%(50,797) of all deaths each year are related to heart disease and accounted for 12% (A$4Billion) of total recurrent health expenditure. This innovative research aims at developing a single biventricular assist device (BVAD) driven by a magnetically suspended double-sided centrifugal pump impeller. Current techniques require two implantable devices, thus preventing smaller patients from access to BVAD technology. The expected outcomes will be a significantly small and compact device and provide an alternative to open-heart transplantation, thus helping to alleviate the demand on donor hearts, as well as the strain on the Australian Heath Care System caused by cardiovascular disease.Read moreRead less
Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO an ....Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO and University of Queensland, as well as with companies involved in the commercialisation of polyurethane based medical devices (Aortech P/L), this group is well placed to continue the research at a more applied level once the early basic stage is complete.Read moreRead less
Development of an implantable blood flow and pressure monitor for pulmonary hypertension. The aim is to develop an implantable device for continuous measurement of blood pressure and flow rate in the pulmonary artery. The device is to store data and download it on request to an external device. Development steps include design of the sensor lead incorporating impedance electrodes and a pressure transducer, numerical modelling of the electrode system, characterising pressure and flow waveforms f ....Development of an implantable blood flow and pressure monitor for pulmonary hypertension. The aim is to develop an implantable device for continuous measurement of blood pressure and flow rate in the pulmonary artery. The device is to store data and download it on request to an external device. Development steps include design of the sensor lead incorporating impedance electrodes and a pressure transducer, numerical modelling of the electrode system, characterising pressure and flow waveforms for condensed storage, establishing flow sensor and blood flow relationships and assessment of sensor stability and calibration demands. The device will facilitate research in pulmonary hypertension and may lead to clinical devices for monitoring effectiveness of treatment.Read moreRead less
Hybrid radiofrequency/optical catheter for effective atrial fibrillation ablation. This research project aims to advance engineering knowledge by applying an innovative, fibre-optics-based discrete optical coherence tomography to technology used for atrial fibrillation catheter ablation. RadioFrequency catheter-based ablation is far superior to cardiac drug therapy for atrial fibrillation patients. RadioFrequency catheters are not equipped with real-time lesion formation monitoring means, which ....Hybrid radiofrequency/optical catheter for effective atrial fibrillation ablation. This research project aims to advance engineering knowledge by applying an innovative, fibre-optics-based discrete optical coherence tomography to technology used for atrial fibrillation catheter ablation. RadioFrequency catheter-based ablation is far superior to cardiac drug therapy for atrial fibrillation patients. RadioFrequency catheters are not equipped with real-time lesion formation monitoring means, which enable the assessment of continuity-transmurality and prevent extra-cardiac complications, such as steam pops. Optical Coherece Tomography enables non-invasive, microscopic lesion formation assessment in real time during atrial fibrillation ablation procedures. The expected outcomes of this project are to develop a new hybrid fibre-optic/RadioFrequency catheter system and user-friendly driving software that will enable cardiac electrophysiologists to perform three key tasks not previously available.Read moreRead less
Non-invasive control of an implantable rotary blood pump used as a left ventricular assist device. The Holy Grail for developers of rotary blood pumps used as left ventricular assist devices is to control the pump to meet the body's metabolic demand and to do this without the need for implanting additional sensors. The controller must also detect and avoid dangerous states associated with over and under pumping.
In this research we will derive and implement a pump control algorithm that will ....Non-invasive control of an implantable rotary blood pump used as a left ventricular assist device. The Holy Grail for developers of rotary blood pumps used as left ventricular assist devices is to control the pump to meet the body's metabolic demand and to do this without the need for implanting additional sensors. The controller must also detect and avoid dangerous states associated with over and under pumping.
In this research we will derive and implement a pump control algorithm that will allow non-invasive prediction of pump flow, automatic detection of pumping states and adjustments for the metabolic demand of the body. The algorithms will be tested on the bench and in animal and human studies.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0454081
Funder
Australian Research Council
Funding Amount
$276,317.00
Summary
Innovative Assistive Technology for Severely Disabled People. Severe disability costs Australia $1 billion a year and affects about 50,000 people. These people have few options to enhance their independence. The purpose of this grant is to purchase six equipment systems to support high quality research in this field. The new facility builds upon substantial national and international research strengths and collaborations to develop a world lead in assistive technology. This will yield a new gene ....Innovative Assistive Technology for Severely Disabled People. Severe disability costs Australia $1 billion a year and affects about 50,000 people. These people have few options to enhance their independence. The purpose of this grant is to purchase six equipment systems to support high quality research in this field. The new facility builds upon substantial national and international research strengths and collaborations to develop a world lead in assistive technology. This will yield a new generation of innovative medical devices that give the disabled people more independence, mobility and control over their lives, and form the basis of a niche export industry.Read moreRead less
Understanding glycopolymer interactions with the extracellular matrix. This project aims to advance knowledge of the biochemical and biophysical structure of the endothelial glycocalyx, a dynamic cell surface extracellular matrix rich in proteoglycans and glycosaminoglycans. It will be the first to explore how charged glycopolymers interact with this dynamic interface with the goal to develop a model of the glycocalyx lifecycle. This project is expected to enable the transfer of skills, knowledg ....Understanding glycopolymer interactions with the extracellular matrix. This project aims to advance knowledge of the biochemical and biophysical structure of the endothelial glycocalyx, a dynamic cell surface extracellular matrix rich in proteoglycans and glycosaminoglycans. It will be the first to explore how charged glycopolymers interact with this dynamic interface with the goal to develop a model of the glycocalyx lifecycle. This project is expected to enable the transfer of skills, knowledge and ideas as well as advanced research and industrial training for young scientists. Knowledge derived from this project is expected to enable future innovation in molecules with tailored interactions with the glycocalyx with significant benefits for researchers, manufacturers and end users. Read moreRead less